BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33459165)

  • 1. Nicotine, smoking, podocytes, and diabetic nephropathy.
    Jaimes EA; Zhou MS; Siddiqui M; Rezonzew G; Tian R; Seshan SV; Muwonge AN; Wong NJ; Azeloglu EU; Fornoni A; Merscher S; Raij L
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F442-F453. PubMed ID: 33459165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 3. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress.
    Lan X; Lederman R; Eng JM; Shoshtari SS; Saleem MA; Malhotra A; Singhal PC
    PLoS One; 2016; 11(12):e0167071. PubMed ID: 27907022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.
    Liu N; Xu L; Shi Y; Zhuang S
    J Diabetes Res; 2017; 2017():3560238. PubMed ID: 28512641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
    Wang Y; Feng F; He W; Sun L; He Q; Jin J
    Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
    Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
    J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
    Wang F; Li R; Zhao L; Ma S; Qin G
    Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
    Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
    Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
    Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
    Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
    Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
    J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.